Kyrgyzstan Completes Drug Database Implementation

Kyrgyzstan has finalized the implementation of a comprehensive drug database system, a move aimed at combating smuggling and enhancing the tracking of pharmaceuticals within the country. Nuradin Karatayev, head of the department at the Department of Medicines and Medical Devices, announced the completion of the system.

The database is designed to streamline the process of drug circulation, from their entry into the country through registration and distribution to the final consumer. Karatayev highlighted its utility during the COVID-19 pandemic, noting the absence of an automated system for tracking drug inventory. The new database provides clear, up-to-date statistics, enabling authorities to anticipate potential shortages and alert suppliers in advance.

Currently, the database contains over 110 million packages of medication, with approximately 36 million packages already accounted for as sold or written off. Karatayev indicated that while an exact percentage of illegally imported drugs is difficult to pinpoint, estimates based on 2023 data suggest it was around 40-45%. However, this figure is reportedly decreasing with the introduction of new programs, and the legal turnover of medicines is increasing by 2 billion soms annually.

To further combat shortages and improve access, Kyrgyzstan established the state enterprise "Kyrgyzfarmatsiya." This entity works directly with suppliers to ensure a steady supply of medications to hospitals. The country procures medicines valued at approximately 30-35 billion soms annually, a figure comparable to the budget of a medium-sized factory in Europe. Karatayev also mentioned plans to include medications costing less than 100 soms in the tracking system starting next year.

For public access, an application called "Dary-Darmek" has been developed, allowing citizens to verify drug registration and availability. Karatayev emphasized that for any medication to be sold in pharmacies, it must meet two conditions: registration within the Kyrgyz Republic and a quality certificate. The department, equipped with a laboratory, rigorously tests each batch for safety and quality before it reaches pharmacies.